EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function

EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development ... https://t.co/TM7d9rpfek

RT @BMC_series: Cutaneous adverse drug reactions (CADR): New #BMCCancer study contributes to the mechanistic understanding of the clinicall…

Cutaneous adverse drug reactions (CADR): New #BMCCancer study contributes to the mechanistic understanding of the clinically observed CADR during therapy with EGFR inhibitors 👉 https://t.co/iPi6zBiCcw @JNJNews @NatResCancer https://t.co/5nDQJ8zkN2

EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function https://t.co/TM7d9rpfek